SecurityPAR / Par Technology Corp. (698884103)
Institutional Owners48 (7 N-Q Owners)
Institutional Shares9,998,003 - 62.45% (ex. N-Q)
Common Shares Outstanding16,010,818 shares (as of 2017-12-31)
Institutional Value$ 135,152,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Par Technology Corp. (NYSE:PAR) has 48 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,998,003 shares. Largest shareholders include Voss Capital Llc, ADW Capital Partners, L.P., Wellington Trust Co NA, Wellington Management Group LLP, Dimensional Fund Advisors Lp, Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity Portfolio, Stone House Capital Management, LLC, Sterling Capital Management Inc, Wedbush Securities Inc, and Vanguard Group Inc.

Par Technology Corp. (NYSE:PAR) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-14 13F-HR ROYAL BANK OF CANADA 2 0 -100.00 0 0
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 129 837 548.84 1 8 700.00
2018-02-13 13F-HR Renaissance Technologies LLC 315,700 227,100 -28.06 3,296 2,123 -35.59
2017-10-26 13F-HR Acrospire Investment Management LLC 3,757 0 -100.00 32 0 -100.00
2018-02-14 13F-HR Brasada Capital Management, Lp 130,580 1,141
2018-02-27 N-Q Northern Funds (see advisory)
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 4,501 10,876 141.64 47 101 114.89
2018-03-29 SC 13G ADW Capital Partners, L.P. 1,100,000
2017-11-14 13F-HR UBS Group AG 804 0 -100.00 7 0 -100.00
2017-11-09 13F-HR TFS CAPITAL LLC 22,286 0 -100.00 190 0 -100.00
2018-04-18 13F-HR Cornerstone Advisors, Inc. 0 21 0 2
2018-02-14 13F-HR DEUTSCHE BANK AG\ 89,897 48,100 -46.49 938 449 -52.13
2018-02-01 13F-HR Granite Investment Partners, LLC 111,984 111,984 0.00 1,169 1,047 -10.44
2018-02-13 13F-HR O'SHAUGHNESSY ASSET MANAGEMENT, LLC 0 7,994 0 75
2018-02-09 13F-HR BlackRock Inc. 272,117 273,221 0.41 2,841 2,554 -10.10
2018-02-14 13F-HR VANGUARD GROUP INC 321,159 400,082 24.57 3,353 3,741 11.57
2018-01-25 13F-HR PERRITT CAPITAL MANAGEMENT INC 123,248 123,248 0.00 1,287 1,152 -10.49
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 30,335 30,335 0.00 317 284 -10.41
2017-11-09 13F-HR/A-1 JACOBS LEVY EQUITY MANAGEMENT, INC 10,488 0 -100.00 75 0 -100.00
2018-02-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 164,642 107,542 -34.68 1,719 1,006 -41.48
2018-02-08 SC 13G Wellington Management Group LLP 1,017,503
2018-02-14 13F-HR Stone House Capital Management, LLC 675,000 6,311
2017-11-28 N-Q Ancora Trust (see advisory)
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 28,000 395
2018-01-26 N-Q Rbb Fund, Inc. (see advisory)
2018-02-15 13F-HR Municipal Employees' Retirement System of Michigan 43,500 407
2018-02-14 SC 13G/A ELIOT ROSE ASSET MANAGEMENT LLC 1,247,634 0 -100.00
2018-02-14 13F-HR NORTHERN TRUST CORP 48,225 51,059 5.88 504 477 -5.36
2018-02-14 13F-HR BlueCrest Capital Management Ltd 21,767 204
2018-02-01 13F-HR ALGERT GLOBAL LLC 134,077 237,219 76.93 1,400 2,218 58.43
2018-02-08 13F-HR Matarin Capital Management, LLC 11,167 11,167 0.00 116,583 104,411 -10.44
2018-02-08 SC 13G Wellington Trust Co NA 1,017,503
2018-02-14 13F-HR RBF Capital, LLC 70,685 70,685 0.00 738 661 -10.43
2018-02-09 13F-HR WEDBUSH SECURITIES INC 499,406 489,734 -1.94 5,214 4,579 -12.18
2018-02-14 13F-HR MORGAN STANLEY 1,080 636 -41.11 11 6 -45.45
2018-03-01 N-Q Vericimetry Funds (see advisory)
2017-11-22 N-Q Bridgeway Funds Inc (see advisory)
2018-02-09 13F-HR Virtu Financial LLC 18,638 0 -100.00 195 0 -100.00
2018-02-07 13F-HR OPPENHEIMER ASSET MANAGEMENT INC. 1,634 0 -100.00 17 0 -100.00
2018-02-01 13F-HR Nationwide Fund Advisors 1,700 0 -100.00 18 0 -100.00
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 4,142 407 -90.17 44 4 -90.91
2018-02-09 SC 13G DIMENSIONAL FUND ADVISORS LP 921,978
2018-02-13 SC 13G/A STERLING CAPITAL MANAGEMENT INC 896,863 673,226 -24.94
2018-02-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 3,005 0 -100.00 31 0 -100.00
2018-02-08 SC 13G/A Wellington Trust Company, National Association Multiple Common Trust Funds Trust, Micro Cap Equity Portfolio 868,071 875,516 0.86
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 14,940 140
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 27,309 27,309 0.00 285 255 -10.53
2017-11-13 13F-HR EAGLE GLOBAL ADVISORS LLC 16,690 0 -100.00 142 0 -100.00
2018-04-16 SC 13D/A Voss Capital Llc 1,103,314 1,103,314 0.00
2018-02-12 13F-HR EAM Investors, LLC 66,287 0 -100.00 692 0 -100.00
2018-02-28 N-Q Ishares Trust (see advisory)
2018-02-05 13F-HR THOMPSON DAVIS & CO., INC. 2,875 0 -100.00 30 0 -100.00
2018-02-14 13F-HR BARCLAYS PLC 34 34 0.00 0 0
2018-02-13 13F-HR Sullivan, Bruyette, Speros & Blaney, Inc. 26,079 26,079 0.00 272 244 -10.29
2018-02-14 13F-HR Ancora Advisors, LLC 189,787 0 -100.00 1,981 0 -100.00
2018-02-06 13F-HR Russell Investments Group, Ltd. 800 800 0.00 8 7 -12.50
2018-02-13 13F-HR JP Morgan Chase & Co 3,124 0 -100.00 31 0 -100.00
2017-11-08 13F-HR Friedberg Investment Management 95,130 37,850 -60.21 810 395 -51.23
2018-02-09 13F-HR Bank of New York Mellon Corp 11,887 12,463 4.85 124 116 -6.45
2018-02-14 13F-HR GSA CAPITAL PARTNERS LLP 19,400 15,300 -21.13 203 143 -29.56
2018-02-09 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 36,594 36,594 0.00 382 342 -10.47
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-14 13F-HR Squarepoint Ops LLC 16,500 16,500 0.00 172 154 -10.47
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 48 0 -100.00 1 0 -100.00

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( PAR / Par Technology Corp. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 698884103